Pharmacology of iron transport.

Pharmacology of iron transport.
复制标题

DOI:
10.1146/annurev-pharmtox-010611-134648
复制
发表时间:
2013
影响因子:
12.5
通讯作者:
Wessling-Resnick M
Wessling-Resnick M
中科院分区:
医学1区
文献类型:
--
作者:
Byrne SL;Krishnamurthy D;Wessling-Resnick M

文献摘要

参考文献

被引文献

相似文献

阐明铁摄取、储存和分布调控的分子基础对于理解铁的稳态是必要的。正在出现一些药理工具来识别和区分不同的铁运输途径。对铁摄取有促进或抑制作用的小分子可以帮助表征铁运输的机制要素和转运蛋白在这些过程中的作用。特别是,铁络合剂可以作为潜在的药理工具来缓解铁超载的疾病。本文综述了铁转运的药理作用,介绍了铁转运膜蛋白和已知的铁转运抑制剂。
Elucidating the molecular basis for the regulation of iron uptake, storage, and distribution is necessary to understand iron homeostasis. Pharmacological tools are emerging to identify and distinguish among different iron transport pathways. Stimulatory or inhibitory small molecules with effects on iron uptake can help characterize the mechanistic elements of iron transport and the roles of the transporters involved in these processes. In particular, iron chelators can serve as potential pharmacological tools to alleviate diseases of iron overload. This review focuses on the pharmacology of iron transport, introducing iron transport membrane proteins and known inhibitors.
DOI: 10.1053/j.seminhematol.2009.06.004
发表时间: 2009-10-01
影响因子: 3.6
作者:
Beaumont, Carole;Delaby, Constance
通讯作者: Delaby, Constance
DOI: 10.1007/s003600050085
发表时间: 1997-07-01
期刊: JOURNAL OF COMPARATIVE PHYSIOLOGY B-BIOCHEMICAL SYSTEMIC AND ENVIRONMENTAL PHYSIOLOGY
影响因子: --
作者:
Chua, ACG;Morgan, EH
通讯作者: Morgan, EH
DOI: 10.1007/bf01308057
发表时间: 1980-01-01
影响因子: 3.1
作者:
BATEY, RG;FONG, PLC;SHERLOCK, S
通讯作者: SHERLOCK, S
DOI: 10.1074/jbc.m000713200
发表时间: 2000-06-30
影响因子: 4.8
作者:
Abboud, S;Haile, DJ
通讯作者: Haile, DJ
DOI: 10.1038/nchembio.402
发表时间: 2010-08
影响因子: 14.8
作者:
Bao G;Clifton M;Hoette TM;Mori K;Deng SX;Qiu A;Viltard M;Williams D;Paragas N;Leete T;Kulkarni R;Li X;Lee B;Kalandadze A;Ratner AJ;Pizarro JC;Schmidt-Ott KM;Landry DW;Raymond KN;Strong RK;Barasch J
通讯作者: Barasch J